[1]
Villalobo, A. et al. 2013. Targeting the Calmodulin-Regulated ErbB/Grb7 Signaling Axis in Cancer Therapy. Journal of Pharmacy & Pharmaceutical Sciences. 16, 2 (Apr. 2013), 177–189. DOI:https://doi.org/10.18433/J3V59V.